{"SPADE_UN_17041": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17041", "Peptide Name": 9, "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "YSX", "Sequence Length": 3, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C12H14N2O4", "Mass": 39610, "PI": 6.09, "Net Charge": 0, "Hydrophobicity": -0.7, "Half Life": "Mammalian:2.8 hourYeast:10 minE.coli:2 min", "Literature": [{"Title": "Tumor-cell-targeted methionine-enkephalin analogues containing unnatural amino acids design, synthesis, and in vitro antitumor activity.", "Pubmed ID": "16722632", "Reference": "Cancer Res. 2004 Aug 15;64(16)5812-7.", "Author": "Do√±ate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, Mazar AP.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16722632"}], "Frequent Amino Acids": "SXY", "Absent Amino Acids": "ACDEFGHIKLMNOPQRTUVW", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 1, "Polar Residues": 2, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_00059", "Similarity": 1.0, "Sequence": "AYPGNGVHCGKYSCTVDKQTAIGNIGNNAA"}, {"SPADE_ID": "SPADE_N_00103", "Similarity": 1.0, "Sequence": "VFHAYSARGVRNNYKSAVGPADWVISAVRGFIHG"}, {"SPADE_ID": "SPADE_N_00117", "Similarity": 1.0, "Sequence": "NRWTNAYSAALGCAVPGVKYGKKLGGVWGAVIGGVGGAAVCGLAGYVRKG"}]}}}